Joseph P Balthasar
- University at Buffalo · Pharmacology (NIH department code)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
FY2025 NIH rank #20,489
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1972631Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0001-6340-9370Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pharmacology
NIH Funding · FY2025
Linked Award Amount
$789K
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#20,489
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Joseph P Balthasar as a PI. Multi-PI records show the full award amount for context.
- 5R01CA275967-03R01Contact PIPharmacokinetic / Pharmacodynamic Optimization of ADC Therapy for Acute Myeloid LeukemiaUniversity at Buffalo · Pharmacology (NIH department code)$427.6Kaward amount
- 5R01CA256928-05R01Contact PIEnhancement of ADC selectivity by inverse targeting: Mechanistic studies and optimizationUniversity at Buffalo · Pharmacology (NIH department code)$361.5Kaward amount
Award organization
Organizations that administered FY2025 awards listing Joseph P Balthasar as a PI.
FY2025 award administered by University at Buffalo (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity at Buffalo
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Joseph P Balthasar.